Charles Schwab’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.17M | Buy |
142,112
+18,066
| +15% | +$530K | ﹤0.01% | 2405 |
|
|
2025
Q1 | $3.19M | Sell |
124,046
-3,150
| -2% | -$81K | ﹤0.01% | 2460 |
|
|
2024
Q4 | $3.67M | Buy |
127,196
+3,825
| +3% | +$110K | ﹤0.01% | 2479 |
|
|
2024
Q3 | $2.93M | Buy |
123,371
+81,901
| +197% | +$1.94M | ﹤0.01% | 2594 |
|
|
2024
Q2 | $717K | Buy |
41,470
+29,787
| +255% | +$515K | ﹤0.01% | 3048 |
|
|
2024
Q1 | $261K | Sell |
11,683
-1
| -0% | -$22 | ﹤0.01% | 3199 |
|
|
2023
Q4 | $214K | Hold |
11,684
| – | – | ﹤0.01% | 3269 |
|
|
2023
Q3 | $203K | Hold |
11,684
| – | – | ﹤0.01% | 3287 |
|
|
2023
Q2 | $213K | Buy |
11,684
+9,150
| +361% | +$167K | ﹤0.01% | 3296 |
|
|
2023
Q1 | $43.5K | Hold |
2,534
| – | – | ﹤0.01% | 3371 |
|
|
2022
Q4 | $58.9K | Hold |
2,534
| – | – | ﹤0.01% | 3327 |
|
|
2022
Q3 | $57K | Buy |
+2,534
| New | +$57K | ﹤0.01% | 3300 |
|
|
2022
Q2 | – | Sell |
-10,243
| Closed | -$366K | – | 3656 |
|
|
2022
Q1 | $366K | Buy |
10,243
+4,156
| +68% | +$149K | ﹤0.01% | 3166 |
|
|
2021
Q4 | $530K | Buy |
6,087
+402
| +7% | +$35K | ﹤0.01% | 3125 |
|
|
2021
Q3 | $653K | Buy |
+5,685
| New | +$653K | ﹤0.01% | 3051 |
|